More news
- Axalta releases Q1 2024 results
- PPG again earns EcoVadis gold rating for sustainability practices, ranking among top 7% of...
- Baikowski® France 2030 plan winner for its innovative project to decarbonise alumina prod...
- New CEO at BASF: Martin Brudermüller hands over to Markus Kamieth
- Wacker stays below prior-year figures amid lower selling prices in Q1
The relevant regulatory authorities have formally approved Reverdia, the joint venture between Royal DSM and Roquette Frères. Reverdia aims to build on its emerging leadership position for bio-based succinic acid through its proprietary production technology and by ensuring reliable supply to meet the evolving market demands. Bio-based succinic acid is a building block that can be used in the manufacture of polymers, resins and many other products.
The facility, scheduled to be operational by the end of Q3, 2012 will have a capacity of about 10kt and is located on the Roquette site in Cassano Spinola, Italy.
